#category	term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
GO Process	GO:0051173	Positive regulation of nitrogen compound metabolic process	12	3166	0.79	4.76e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0010604	Positive regulation of macromolecule metabolic process	12	3533	0.75	8.84e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0010628	Positive regulation of gene expression	9	1146	1.11	8.84e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,CDKN2A
GO Process	GO:1901987	Regulation of cell cycle phase transition	7	431	1.43	8.84e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,PBRM1,CDKN2A
GO Process	GO:0010165	Response to X-ray	4	31	2.33	1.07e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,TP53,ATM,ERCC6
GO Process	GO:0045935	Positive regulation of nucleobase-containing compound metabolic process	10	2056	0.9	1.90e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0031325	Positive regulation of cellular metabolic process	11	3114	0.76	3.15e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0000075	Cell cycle checkpoint signaling	5	157	1.72	4.64e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,APC,TP53,ATM,ERCC6
GO Process	GO:0045786	Negative regulation of cell cycle	6	359	1.44	5.11e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,CDKN2A
GO Process	GO:2000045	Regulation of G1/S transition of mitotic cell cycle	5	164	1.7	5.11e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386593,9606.ENSP00000418915	APC,TP53,ATM,PBRM1,CDKN2A
GO Process	GO:0042127	Regulation of cell population proliferation	9	1669	0.95	5.22e-05	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,PGR,HDAC1,AR,PBRM1,CDKN2A
GO Process	GO:0051726	Regulation of cell cycle	8	1108	1.07	5.22e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,PBRM1,CDK12,CDKN2A
GO Process	GO:0008630	Intrinsic apoptotic signaling pathway in response to DNA damage	4	75	1.94	0.00010	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,TP53,ATM,ERCC6
GO Process	GO:0042325	Regulation of phosphorylation	8	1251	1.02	0.00010	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,ERCC6,AR,CDK12,CDKN2A
GO Process	GO:0045944	Positive regulation of transcription by RNA polymerase II	8	1250	1.02	0.00010	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	TP53,ATM,PGR,ERCC6,HDAC1,AR,CDK12,CDKN2A
GO Process	GO:0010605	Negative regulation of macromolecule metabolic process	10	2760	0.77	0.00012	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,CDKN2A
GO Process	GO:0048519	Negative regulation of biological process	12	5313	0.57	0.00012	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0090399	Replicative senescence	3	16	2.49	0.00012	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
GO Process	GO:0007346	Regulation of mitotic cell cycle	6	493	1.3	0.00014	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,ATM,PBRM1,CDKN2A
GO Process	GO:0035264	Multicellular organism growth	4	88	1.87	0.00014	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	TP53,ATM,ERCC6,AR
GO Process	GO:0048522	Positive regulation of cellular process	12	5584	0.55	0.00016	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0008340	Determination of adult lifespan	3	21	2.37	0.00018	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,TP53,ATM
GO Process	GO:0031323	Regulation of cellular metabolic process	12	5681	0.54	0.00018	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0042981	Regulation of apoptotic process	8	1462	0.95	0.00018	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,HDAC1,AR,CDKN2A
GO Process	GO:0051052	Regulation of DNA metabolic process	6	541	1.26	0.00018	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,TP53,ATM,ERCC6,PBRM1,CDKN2A
GO Process	GO:0000077	DNA damage checkpoint signaling	4	105	1.8	0.00019	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,TP53,ATM,ERCC6
GO Process	GO:0080090	Regulation of primary metabolic process	12	5899	0.52	0.00022	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0031324	Negative regulation of cellular metabolic process	9	2265	0.81	0.00023	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,HDAC1,AR,CDKN2A
GO Process	GO:0045595	Regulation of cell differentiation	8	1582	0.92	0.00025	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	APC,TP53,NTRK2,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:2001020	Regulation of response to DNA damage stimulus	5	316	1.41	0.00031	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000386593,9606.ENSP00000418915	TP53,ATM,ERCC6,PBRM1,CDKN2A
GO Process	GO:0007093	Mitotic cell cycle checkpoint signaling	4	127	1.71	0.00033	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,APC,TP53,ATM
GO Process	GO:0051172	Negative regulation of nitrogen compound metabolic process	9	2403	0.79	0.00034	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,HDAC1,AR,CDKN2A
GO Process	GO:0001932	Regulation of protein phosphorylation	7	1108	1.02	0.00037	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000398880,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,ERCC6,CDK12,CDKN2A
GO Process	GO:0050793	Regulation of developmental process	9	2492	0.77	0.00038	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0048523	Negative regulation of cellular process	11	4736	0.58	0.00042	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0051053	Negative regulation of DNA metabolic process	4	149	1.64	0.00046	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,TP53,ATM,ERCC6
GO Process	GO:0006357	Regulation of transcription by RNA polymerase II	9	2586	0.76	0.00049	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:0008285	Negative regulation of cell population proliferation	6	713	1.14	0.00049	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	APC,TP53,ATM,AR,PBRM1,CDKN2A
GO Process	GO:0043516	Regulation of DNA damage response, signal transduction by p53 class mediator	3	39	2.1	0.00052	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
GO Process	GO:0010468	Regulation of gene expression	11	4899	0.57	0.00055	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Process	GO:2001022	Positive regulation of response to DNA damage stimulus	4	168	1.59	0.00065	9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000386593,9606.ENSP00000418915	ATM,ERCC6,PBRM1,CDKN2A
GO Process	GO:0060748	Tertiary branching involved in mammary gland duct morphogenesis	2	3	3.04	0.00081	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
GO Process	GO:0048583	Regulation of response to stimulus	10	3931	0.62	0.0010	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,HDAC1,AR,PBRM1,CDKN2A
GO Process	GO:0006302	Double-strand break repair	4	204	1.51	0.0012	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,TP53,ATM,ERCC6
GO Process	GO:0010332	Response to gamma radiation	3	55	1.95	0.0012	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	TP53,ATM,ERCC6
GO Process	GO:0043523	Regulation of neuron apoptotic process	4	216	1.48	0.0014	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616	MSH2,TP53,NTRK2,ATM
GO Process	GO:0048584	Positive regulation of response to stimulus	8	2131	0.79	0.0014	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,TP53,NTRK2,ATM,ERCC6,AR,PBRM1,CDKN2A
GO Process	GO:0090398	Cellular senescence	3	60	1.91	0.0014	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
GO Process	GO:0051338	Regulation of transferase activity	6	912	1.03	0.0015	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000398880,9606.ENSP00000418915	APC,TP53,NTRK2,ERCC6,CDK12,CDKN2A
GO Process	GO:0008406	Gonad development	4	226	1.46	0.0016	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000363822	MSH2,ATM,PGR,AR
GO Process	GO:0065009	Regulation of molecular function	9	3085	0.68	0.0016	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ERCC6,HDAC1,AR,CDK12,CDKN2A
GO Process	GO:0035556	Intracellular signal transduction	7	1518	0.88	0.0018	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,AR,CDKN2A
GO Process	GO:0051276	Chromosome organization	6	968	1.01	0.0019	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593	MSH2,TP53,ATM,ERCC6,HDAC1,PBRM1
GO Process	GO:0045934	Negative regulation of nucleobase-containing compound metabolic process	7	1562	0.87	0.0020	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,TP53,ATM,ERCC6,HDAC1,AR,CDKN2A
GO Process	GO:2000134	Negative regulation of G1/S transition of mitotic cell cycle	3	75	1.82	0.0023	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	APC,TP53,ATM
GO Process	GO:0050790	Regulation of catalytic activity	8	2370	0.74	0.0025	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ERCC6,HDAC1,CDK12,CDKN2A
GO Process	GO:0044773	Mitotic DNA damage checkpoint signaling	3	81	1.78	0.0028	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,TP53,ATM
GO Process	GO:0048511	Rhythmic process	4	270	1.39	0.0029	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000325120,9606.ENSP00000362649	TP53,NTRK2,PGR,HDAC1
GO Process	GO:0000278	Mitotic cell cycle	5	631	1.11	0.0036	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386593	MSH2,APC,TP53,ATM,PBRM1
GO Process	GO:0030071	Regulation of mitotic metaphase/anaphase transition	3	91	1.73	0.0036	9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000386593	APC,ATM,PBRM1
GO Process	GO:0071495	Cellular response to endogenous stimulus	6	1103	0.95	0.0036	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822	APC,TP53,NTRK2,PGR,HDAC1,AR
GO Process	GO:0030154	Cell differentiation	9	3507	0.62	0.0037	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR
GO Process	GO:0072331	Signal transduction by p53 class mediator	3	93	1.72	0.0037	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,TP53,ATM
GO Process	GO:0051054	Positive regulation of DNA metabolic process	4	304	1.33	0.0040	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000386593	MSH2,ATM,ERCC6,PBRM1
GO Process	GO:0051246	Regulation of protein metabolic process	8	2622	0.7	0.0045	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000398880,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,ERCC6,HDAC1,CDK12,CDKN2A
GO Process	GO:0051095	Regulation of helicase activity	2	12	2.44	0.0046	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
GO Process	GO:0031058	Positive regulation of histone modification	3	111	1.65	0.0056	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	TP53,ATM,ERCC6
GO Process	GO:1902749	Regulation of cell cycle G2/M phase transition	3	111	1.65	0.0056	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
GO Process	GO:1903624	Regulation of DNA catabolic process	2	14	2.37	0.0056	9606.ENSP00000278616,9606.ENSP00000418915	ATM,CDKN2A
GO Process	GO:0007049	Cell cycle	6	1246	0.9	0.0057	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,ATM,PBRM1,CDKN2A
GO Process	GO:0051239	Regulation of multicellular organismal process	8	2749	0.68	0.0057	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,HDAC1,AR,PBRM1,CDKN2A
GO Process	GO:0006974	Cellular response to DNA damage stimulus	5	744	1.04	0.0065	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,APC,TP53,ATM,ERCC6
GO Process	GO:0048731	System development	9	3867	0.58	0.0070	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR
GO Process	GO:0010224	Response to UV-B	2	17	2.29	0.0075	9606.ENSP00000233146,9606.ENSP00000348089	MSH2,ERCC6
GO Process	GO:0043517	Positive regulation of DNA damage response, signal transduction by p53 class mediator	2	17	2.29	0.0075	9606.ENSP00000278616,9606.ENSP00000418915	ATM,CDKN2A
GO Process	GO:0071310	Cellular response to organic substance	7	2019	0.76	0.0076	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822	APC,TP53,NTRK2,ATM,PGR,HDAC1,AR
GO Process	GO:0030183	B cell differentiation	3	129	1.58	0.0077	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,TP53,ATM
GO Process	GO:0043549	Regulation of kinase activity	5	778	1.02	0.0077	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000398880,9606.ENSP00000418915	APC,NTRK2,ERCC6,CDK12,CDKN2A
GO Process	GO:0030889	Negative regulation of B cell proliferation	2	19	2.24	0.0087	9606.ENSP00000278616,9606.ENSP00000418915	ATM,CDKN2A
GO Process	GO:0045945	Positive regulation of transcription by RNA polymerase III	2	19	2.24	0.0087	9606.ENSP00000348089,9606.ENSP00000363822	ERCC6,AR
GO Process	GO:0007623	Circadian rhythm	3	139	1.55	0.0092	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000362649	TP53,NTRK2,HDAC1
GO Process	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	2	20	2.22	0.0093	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0050864	Regulation of B cell activation	3	140	1.55	0.0093	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000418915	MSH2,ATM,CDKN2A
GO Process	GO:0042327	Positive regulation of phosphorylation	5	826	1.0	0.0095	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	TP53,NTRK2,ATM,ERCC6,AR
GO Process	GO:0009411	Response to UV	3	150	1.52	0.0108	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000348089	MSH2,TP53,ERCC6
GO Process	GO:0090304	Nucleic acid metabolic process	7	2203	0.72	0.0117	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,ATM,ERCC6,AR,CDK12,CDKN2A
GO Process	GO:0043066	Negative regulation of apoptotic process	5	891	0.96	0.0125	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822	MSH2,TP53,NTRK2,HDAC1,AR
GO Process	GO:0010661	Positive regulation of muscle cell apoptotic process	2	25	2.12	0.0126	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
GO Process	GO:0051240	Positive regulation of multicellular organismal process	6	1505	0.82	0.0131	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593	MSH2,APC,NTRK2,HDAC1,AR,PBRM1
GO Process	GO:0042659	Regulation of cell fate specification	2	26	2.1	0.0134	9606.ENSP00000362649,9606.ENSP00000363822	HDAC1,AR
GO Process	GO:0051247	Positive regulation of protein metabolic process	6	1512	0.81	0.0134	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,ERCC6,CDKN2A
GO Process	GO:1901700	Response to oxygen-containing compound	6	1547	0.8	0.0146	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	APC,TP53,NTRK2,ATM,ERCC6,AR
GO Process	GO:0016070	RNA metabolic process	6	1550	0.8	0.0147	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	TP53,ATM,ERCC6,AR,CDK12,CDKN2A
GO Process	GO:0071480	Cellular response to gamma radiation	2	29	2.05	0.0156	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0033554	Cellular response to stress	6	1572	0.8	0.0157	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,CDKN2A
GO Process	GO:0043170	Macromolecule metabolic process	10	5781	0.45	0.0163	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,HDAC1,AR,CDK12,CDKN2A
GO Process	GO:0044093	Positive regulation of molecular function	6	1587	0.79	0.0163	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,NTRK2,ERCC6,HDAC1,AR,CDKN2A
GO Process	GO:0045736	Negative regulation of cyclin-dependent protein serine/threonine kinase activity	2	30	2.04	0.0163	9606.ENSP00000257430,9606.ENSP00000418915	APC,CDKN2A
GO Process	GO:0051128	Regulation of cellular component organization	7	2365	0.69	0.0163	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,AR,PBRM1,CDKN2A
GO Process	GO:0007094	Mitotic spindle assembly checkpoint signaling	2	31	2.02	0.0167	9606.ENSP00000257430,9606.ENSP00000278616	APC,ATM
GO Process	GO:0044089	Positive regulation of cellular component biogenesis	4	500	1.12	0.0167	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616	APC,TP53,NTRK2,ATM
GO Process	GO:0048585	Negative regulation of response to stimulus	6	1612	0.79	0.0167	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822	APC,TP53,ATM,ERCC6,HDAC1,AR
GO Process	GO:2000108	Positive regulation of leukocyte apoptotic process	2	31	2.02	0.0167	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
GO Process	GO:0042771	Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	2	32	2.01	0.0168	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
GO Process	GO:0043065	Positive regulation of apoptotic process	4	507	1.11	0.0168	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	APC,TP53,ATM,CDKN2A
GO Process	GO:0046777	Protein autophosphorylation	3	189	1.42	0.0168	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000398880	NTRK2,ATM,CDK12
GO Process	GO:0051249	Regulation of lymphocyte activation	4	508	1.11	0.0168	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,ATM,PBRM1,CDKN2A
GO Process	GO:0009887	Animal organ morphogenesis	5	997	0.92	0.0170	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822	TP53,NTRK2,PGR,HDAC1,AR
GO Process	GO:1902533	Positive regulation of intracellular signal transduction	5	997	0.92	0.0170	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000363822,9606.ENSP00000418915	TP53,NTRK2,ATM,AR,CDKN2A
GO Process	GO:0006351	Transcription, DNA-templated	4	518	1.1	0.0171	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000398880	TP53,ERCC6,AR,CDK12
GO Process	GO:0031401	Positive regulation of protein modification process	5	1018	0.91	0.0179	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	TP53,NTRK2,ATM,ERCC6,CDKN2A
GO Process	GO:0006915	Apoptotic process	5	1041	0.9	0.0191	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,TP53,ATM,ERCC6,CDKN2A
GO Process	GO:0009790	Embryo development	5	1049	0.89	0.0196	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000363822	MSH2,TP53,ATM,HDAC1,AR
GO Process	GO:0051130	Positive regulation of cellular component organization	5	1049	0.89	0.0196	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000363822	APC,TP53,NTRK2,ATM,AR
GO Process	GO:0048468	Cell development	6	1719	0.76	0.0200	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,NTRK2,ATM,PGR,ERCC6,AR
GO Process	GO:1901701	Cellular response to oxygen-containing compound	5	1057	0.89	0.0200	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000363822	APC,TP53,NTRK2,ATM,AR
GO Process	GO:1902531	Regulation of intracellular signal transduction	6	1726	0.76	0.0203	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	TP53,NTRK2,ATM,HDAC1,AR,CDKN2A
GO Process	GO:0060429	Epithelium development	5	1069	0.89	0.0208	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822	TP53,ATM,PGR,HDAC1,AR
GO Process	GO:0007165	Signal transduction	9	4714	0.5	0.0209	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,AR,CDKN2A
GO Process	GO:0006354	DNA-templated transcription, elongation	2	40	1.91	0.0218	9606.ENSP00000348089,9606.ENSP00000398880	ERCC6,CDK12
GO Process	GO:0002562	Somatic diversification of immune receptors via germline recombination within a single locus	2	41	1.9	0.0225	9606.ENSP00000233146,9606.ENSP00000278616	MSH2,ATM
GO Process	GO:0006303	Double-strand break repair via nonhomologous end joining	2	43	1.88	0.0242	9606.ENSP00000278616,9606.ENSP00000348089	ATM,ERCC6
GO Process	GO:0006325	Chromatin organization	4	612	1.03	0.0270	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593	TP53,ERCC6,HDAC1,PBRM1
GO Process	GO:0051716	Cellular response to stimulus	10	6357	0.41	0.0284	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,CDKN2A
GO Process	GO:0042063	Gliogenesis	3	248	1.3	0.0286	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000362649	TP53,NTRK2,HDAC1
GO Process	GO:0007167	Enzyme-linked receptor protein signaling pathway	4	641	1.01	0.0314	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000363822	APC,TP53,NTRK2,AR
GO Process	GO:0043009	Chordate embryonic development	4	654	1.0	0.0334	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	MSH2,TP53,ATM,AR
GO Process	GO:0043525	Positive regulation of neuron apoptotic process	2	54	1.78	0.0346	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0045859	Regulation of protein kinase activity	4	663	1.0	0.0347	9606.ENSP00000257430,9606.ENSP00000348089,9606.ENSP00000398880,9606.ENSP00000418915	APC,ERCC6,CDK12,CDKN2A
GO Process	GO:0030518	Intracellular steroid hormone receptor signaling pathway	2	56	1.77	0.0364	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
GO Process	GO:0051348	Negative regulation of transferase activity	3	274	1.25	0.0364	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000418915	APC,TP53,CDKN2A
GO Process	GO:0009968	Negative regulation of signal transduction	5	1252	0.82	0.0369	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000363822	APC,TP53,ATM,HDAC1,AR
GO Process	GO:0000422	Autophagy of mitochondrion	2	57	1.76	0.0370	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
GO Process	GO:0006289	Nucleotide-excision repair	2	57	1.76	0.0370	9606.ENSP00000269305,9606.ENSP00000348089	TP53,ERCC6
GO Process	GO:0008637	Apoptotic mitochondrial changes	2	58	1.75	0.0373	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
GO Process	GO:0006807	Nitrogen compound metabolic process	10	6643	0.39	0.0379	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,HDAC1,AR,CDK12,CDKN2A
GO Process	GO:0051129	Negative regulation of cellular component organization	4	691	0.98	0.0379	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	APC,TP53,ATM,AR
GO Process	GO:0060261	Positive regulation of transcription initiation from RNA polymerase II promoter	2	59	1.75	0.0379	9606.ENSP00000269305,9606.ENSP00000348089	TP53,ERCC6
GO Process	GO:0032786	Positive regulation of DNA-templated transcription, elongation	2	60	1.74	0.0390	9606.ENSP00000348089,9606.ENSP00000398880	ERCC6,CDK12
GO Process	GO:0042221	Response to chemical	8	4010	0.52	0.0406	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822	APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR
GO Process	GO:0009966	Regulation of signal transduction	7	2978	0.59	0.0433	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,HDAC1,AR,CDKN2A
GO Process	GO:0001756	Somitogenesis	2	64	1.71	0.0434	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
GO Process	GO:0006338	Chromatin remodeling	3	303	1.21	0.0445	9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593	ERCC6,HDAC1,PBRM1
GO Process	GO:0051094	Positive regulation of developmental process	5	1332	0.79	0.0455	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593	MSH2,NTRK2,HDAC1,AR,PBRM1
GO Process	GO:0010467	Gene expression	6	2101	0.67	0.0463	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,ERCC6,AR,CDK12,CDKN2A
GO Process	GO:0001934	Positive regulation of protein phosphorylation	4	747	0.94	0.0476	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089	TP53,NTRK2,ATM,ERCC6
GO Process	GO:0007276	Gamete generation	4	756	0.94	0.0492	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000363822	MSH2,ATM,PGR,AR
GO Function	GO:0019899	Enzyme binding	10	2084	0.9	4.78e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,PGR,ERCC6,HDAC1,AR,CDK12,CDKN2A
GO Function	GO:0003682	Chromatin binding	6	584	1.23	0.0012	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593	MSH2,TP53,ERCC6,HDAC1,AR,PBRM1
GO Function	GO:0047485	Protein N-terminus binding	4	109	1.78	0.0012	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649	TP53,ATM,ERCC6,HDAC1
GO Function	GO:0003677	DNA binding	9	2498	0.77	0.0016	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDKN2A
GO Function	GO:0002039	p53 binding	3	70	1.85	0.0103	9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000418915	TP53,HDAC1,CDKN2A
GO Function	GO:0008134	Transcription factor binding	5	587	1.15	0.0131	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	TP53,PGR,HDAC1,AR,CDKN2A
GO Function	GO:0097159	Organic cyclic compound binding	11	6050	0.47	0.0131	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Function	GO:1901363	Heterocyclic compound binding	11	5977	0.48	0.0131	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Function	GO:0097371	MDM2/MDM4 family protein binding	2	12	2.44	0.0169	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
GO Function	GO:0019901	Protein kinase binding	5	702	1.07	0.0185	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,CDK12,CDKN2A
GO Function	GO:0001221	Transcription coregulator binding	3	114	1.64	0.0193	9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822	PGR,HDAC1,AR
GO Function	GO:0061629	RNA polymerase II-specific DNA-binding transcription factor binding	4	353	1.27	0.0193	9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	TP53,HDAC1,AR,CDKN2A
GO Function	GO:0001091	RNA polymerase II general transcription initiation factor binding	2	25	2.12	0.0389	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
GO Function	GO:0005515	Protein binding	11	7242	0.4	0.0409	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,CDK12,CDKN2A
GO Component	GO:0005694	Chromosome	9	1850	0.9	0.00020	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,PGR,ERCC6,HDAC1,AR,PBRM1,CDKN2A
GO Component	GO:0005654	Nucleoplasm	11	4169	0.64	0.00038	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Component	GO:0000785	Chromatin	7	1285	0.95	0.0015	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	TP53,PGR,ERCC6,HDAC1,AR,PBRM1,CDKN2A
GO Component	GO:0032991	Protein-containing complex	11	5506	0.52	0.0030	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
GO Component	GO:0070603	SWI/SNF superfamily-type complex	3	92	1.73	0.0053	9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593	ERCC6,HDAC1,PBRM1
GO Component	GO:0043232	Intracellular non-membrane-bounded organelle	10	5191	0.5	0.0116	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDKN2A
GO Component	GO:1990391	DNA repair complex	2	43	1.88	0.0485	9606.ENSP00000233146,9606.ENSP00000278616	MSH2,ATM
KEGG	hsa05206	MicroRNAs in cancer	5	159	1.71	9.52e-06	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000418915	APC,TP53,ATM,HDAC1,CDKN2A
KEGG	hsa01524	Platinum drug resistance	4	70	1.97	1.49e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	MSH2,TP53,ATM,CDKN2A
KEGG	hsa05200	Pathways in cancer	6	515	1.28	3.00e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,HDAC1,AR,CDKN2A
KEGG	hsa04110	Cell cycle	4	120	1.74	5.97e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000418915	TP53,ATM,HDAC1,CDKN2A
KEGG	hsa05225	Hepatocellular carcinoma	4	161	1.61	0.00015	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000386593,9606.ENSP00000418915	APC,TP53,PBRM1,CDKN2A
KEGG	hsa04115	p53 signaling pathway	3	72	1.84	0.00064	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
KEGG	hsa05220	Chronic myeloid leukemia	3	75	1.82	0.00064	9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000418915	TP53,HDAC1,CDKN2A
KEGG	hsa05210	Colorectal cancer	3	82	1.78	0.00070	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
KEGG	hsa05165	Human papillomavirus infection	4	324	1.31	0.0013	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649	APC,TP53,ATM,HDAC1
KEGG	hsa04218	Cellular senescence	3	150	1.52	0.0030	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
KEGG	hsa05224	Breast cancer	3	146	1.53	0.0030	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000325120	APC,TP53,PGR
KEGG	hsa05202	Transcriptional misregulation in cancer	3	171	1.46	0.0039	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649	TP53,ATM,HDAC1
KEGG	hsa05203	Viral carcinogenesis	3	183	1.43	0.0044	9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000418915	TP53,HDAC1,CDKN2A
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	3	210	1.37	0.0061	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
KEGG	hsa05219	Bladder cancer	2	40	1.91	0.0065	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
KEGG	hsa05213	Endometrial cancer	2	58	1.75	0.0124	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
KEGG	hsa05217	Basal cell carcinoma	2	63	1.72	0.0137	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
KEGG	hsa05223	Non-small cell lung cancer	2	68	1.68	0.0150	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
KEGG	hsa05212	Pancreatic cancer	2	71	1.67	0.0154	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
KEGG	hsa05214	Glioma	2	71	1.67	0.0154	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
KEGG	hsa05218	Melanoma	2	72	1.66	0.0154	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
KEGG	hsa01522	Endocrine resistance	2	94	1.54	0.0229	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
KEGG	hsa05215	Prostate cancer	2	97	1.53	0.0233	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
KEGG	hsa04722	Neurotrophin signaling pathway	2	112	1.47	0.0295	9606.ENSP00000269305,9606.ENSP00000277120	TP53,NTRK2
KEGG	hsa04114	Oocyte meiosis	2	121	1.43	0.0324	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
KEGG	hsa04919	Thyroid hormone signaling pathway	2	120	1.44	0.0324	9606.ENSP00000269305,9606.ENSP00000362649	TP53,HDAC1
KEGG	hsa04210	Apoptosis	2	131	1.4	0.0355	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
KEGG	hsa05034	Alcoholism	2	146	1.35	0.0422	9606.ENSP00000277120,9606.ENSP00000362649	NTRK2,HDAC1
KEGG	hsa05226	Gastric cancer	2	146	1.35	0.0422	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
KEGG	hsa04310	Wnt signaling pathway	2	154	1.33	0.0431	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
KEGG	hsa04934	Cushing syndrome	2	153	1.33	0.0431	9606.ENSP00000257430,9606.ENSP00000418915	APC,CDKN2A
Reactome	HSA-74160	Gene expression (Transcription)	10	1476	1.05	7.55e-07	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
Reactome	HSA-212436	Generic Transcription Pathway	9	1215	1.08	2.83e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,HDAC1,AR,PBRM1,CDK12,CDKN2A
Reactome	HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	4	62	2.02	3.17e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000398880	MSH2,TP53,ATM,CDK12
Reactome	HSA-3700989	Transcriptional Regulation by TP53	5	361	1.36	0.00070	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000398880	MSH2,TP53,ATM,HDAC1,CDK12
Reactome	HSA-3108232	SUMO E3 ligases SUMOylate target proteins	4	166	1.6	0.00095	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000363822	TP53,PGR,HDAC1,AR
Reactome	HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	2	12	2.44	0.0081	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-73894	DNA Repair	4	310	1.33	0.0081	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,TP53,ATM,ERCC6
Reactome	HSA-2262752	Cellular responses to stress	5	747	1.04	0.0115	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000418915	TP53,ATM,PGR,AR,CDKN2A
Reactome	HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	2	19	2.24	0.0135	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-6804760	Regulation of TP53 Activity through Methylation	2	19	2.24	0.0135	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-5633007	Regulation of TP53 Activity	3	159	1.49	0.0185	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649	TP53,ATM,HDAC1
Reactome	HSA-2559583	Cellular Senescence	3	163	1.48	0.0186	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
Reactome	HSA-4090294	SUMOylation of intracellular receptors	2	28	2.07	0.0209	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
Reactome	HSA-6804758	Regulation of TP53 Activity through Acetylation	2	30	2.04	0.0224	9606.ENSP00000269305,9606.ENSP00000362649	TP53,HDAC1
Reactome	HSA-2559585	Oncogene Induced Senescence	2	33	2.0	0.0254	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
Reactome	HSA-1643685	Disease	6	1702	0.76	0.0269	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000418915	MSH2,APC,TP53,ATM,HDAC1,CDKN2A
Reactome	HSA-6804757	Regulation of TP53 Degradation	2	35	1.97	0.0269	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-5689896	Ovarian tumor domain proteases	2	39	1.93	0.0285	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Reactome	HSA-8853884	Transcriptional Regulation by VENTX	2	39	1.93	0.0285	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
Reactome	HSA-3769402	Deactivation of the beta-catenin transactivating complex	2	42	1.89	0.0301	9606.ENSP00000257430,9606.ENSP00000362649	APC,HDAC1
Reactome	HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	2	45	1.86	0.0318	9606.ENSP00000348089,9606.ENSP00000362649	ERCC6,HDAC1
Reactome	HSA-73762	RNA Polymerase I Transcription Initiation	2	46	1.85	0.0319	9606.ENSP00000348089,9606.ENSP00000362649	ERCC6,HDAC1
Reactome	HSA-9675135	Diseases of DNA repair	2	50	1.82	0.0361	9606.ENSP00000233146,9606.ENSP00000278616	MSH2,ATM
Reactome	HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	2	51	1.81	0.0362	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-383280	Nuclear Receptor transcription pathway	2	52	1.8	0.0364	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
Reactome	HSA-1640170	Cell Cycle	4	658	1.0	0.0371	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000418915	TP53,ATM,HDAC1,CDKN2A
Reactome	HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand	2	55	1.78	0.0380	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
Reactome	HSA-5688426	Deubiquitination	3	280	1.25	0.0393	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000363822	APC,TP53,AR
Reactome	HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	2	60	1.74	0.0411	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	2	60	1.74	0.0411	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Reactome	HSA-8943724	Regulation of PTEN gene transcription	2	60	1.74	0.0411	9606.ENSP00000269305,9606.ENSP00000362649	TP53,HDAC1
WikiPathways	WP1742	TP53 network	3	19	2.41	0.00021	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
WikiPathways	WP179	Cell cycle	4	120	1.74	0.00021	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000418915	TP53,ATM,HDAC1,CDKN2A
WikiPathways	WP2263	Androgen receptor network in prostate cancer	4	109	1.78	0.00021	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	MSH2,TP53,ATM,AR
WikiPathways	WP710	DNA damage response (only ATM dependent)	4	109	1.78	0.00021	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	APC,TP53,ATM,CDKN2A
WikiPathways	WP4262	Breast cancer pathway	4	154	1.63	0.00029	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120	APC,TP53,ATM,PGR
WikiPathways	WP1971	Integrated cancer pathway	3	44	2.05	0.00036	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,TP53,ATM
WikiPathways	WP5087	Malignant pleural mesothelioma	5	434	1.28	0.00042	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,CDKN2A
WikiPathways	WP3959	DNA IR-double strand breaks and cellular response via ATM	3	55	1.95	0.00051	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
WikiPathways	WP45	G1 to S cell cycle control	3	64	1.89	0.00070	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
WikiPathways	WP4216	Chromosomal and microsatellite instability in colorectal cancer 	3	72	1.84	0.00089	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
WikiPathways	WP2261	Glioblastoma signaling pathways	3	82	1.78	0.0011	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
WikiPathways	WP4016	DNA IR-damage and cellular response via ATR	3	81	1.78	0.0011	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,TP53,ATM
WikiPathways	WP1545	miRNAs involved in DNA damage response	2	15	2.34	0.0028	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP4946	DNA repair pathways, full network	3	120	1.61	0.0028	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,ATM,ERCC6
WikiPathways	WP3982	miRNA regulation of p53 pathway in prostate cancer	2	24	2.14	0.0054	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	3	154	1.5	0.0054	9606.ENSP00000277120,9606.ENSP00000362649,9606.ENSP00000363822	NTRK2,HDAC1,AR
WikiPathways	WP3981	miRNA regulation of prostate cancer signaling pathways	2	31	2.02	0.0082	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
WikiPathways	WP170	Nuclear receptors	2	37	1.95	0.0102	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
WikiPathways	WP2516	ATM signaling pathway	2	40	1.91	0.0102	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP2828	Bladder cancer	2	39	1.93	0.0102	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP34	Ovarian infertility	2	36	1.96	0.0102	9606.ENSP00000278616,9606.ENSP00000325120	ATM,PGR
WikiPathways	WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	2	37	1.95	0.0102	9606.ENSP00000269305,9606.ENSP00000362649	TP53,HDAC1
WikiPathways	WP4352	Ciliary landscape	3	214	1.36	0.0102	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000362649	MSH2,APC,HDAC1
WikiPathways	WP3286	Copper homeostasis	2	51	1.81	0.0144	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
WikiPathways	WP3611	Photodynamic therapy-induced AP-1 survival signaling	2	50	1.82	0.0144	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	2	55	1.78	0.0160	9606.ENSP00000257430,9606.ENSP00000362649	APC,HDAC1
WikiPathways	WP3998	Prader-Willi and Angelman syndrome	2	62	1.72	0.0194	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP4155	Endometrial cancer	2	63	1.72	0.0194	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
WikiPathways	WP3651	Pathways affected in adenoid cystic carcinoma	2	65	1.7	0.0198	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP1530	miRNA regulation of DNA damage response	2	71	1.67	0.0209	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP3303	RAC1/PAK1/p38/MMP2 pathway	2	68	1.68	0.0209	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
WikiPathways	WP4255	Non-small cell lung cancer	2	72	1.66	0.0209	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP4674	Head and neck squamous cell carcinoma	2	72	1.66	0.0209	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP4685	Melanoma	2	68	1.68	0.0209	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP707	DNA damage response	2	69	1.68	0.0209	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP254	Apoptosis	2	83	1.6	0.0256	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP138	Androgen receptor signaling pathway	2	90	1.56	0.0267	9606.ENSP00000362649,9606.ENSP00000363822	HDAC1,AR
WikiPathways	WP1772	Apoptosis modulation and signaling	2	89	1.57	0.0267	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP2446	Retinoblastoma gene in cancer	2	87	1.58	0.0267	9606.ENSP00000269305,9606.ENSP00000362649	TP53,HDAC1
WikiPathways	WP4263	Pancreatic adenocarcinoma pathway	2	86	1.58	0.0267	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP5098	T-cell activation SARS-CoV-2	2	88	1.57	0.0267	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
WikiPathways	WP399	Wnt signaling pathway and pluripotency	2	100	1.52	0.0315	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
WikiPathways	WP5322	CKAP4 signaling pathway map	2	114	1.46	0.0396	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
WikiPathways	WP4549	Fragile X syndrome	2	121	1.43	0.0434	9606.ENSP00000277120,9606.ENSP00000418915	NTRK2,CDKN2A
Monarch	HP:0031093	Abnormal breast morphology	7	332	1.54	3.76e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,AR,CDKN2A
Monarch	HP:0100013	Neoplasm of the breast	5	64	2.11	3.76e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	MSH2,APC,TP53,ATM,CDKN2A
Monarch	HP:0012539	Non-Hodgkin lymphoma	4	29	2.35	9.73e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,APC,TP53,ATM
Monarch	HP:0001480	Freckling	4	38	2.24	2.12e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,APC,ERCC6,CDKN2A
Monarch	HP:0100707	Abnormal astrocyte morphology	4	38	2.24	2.12e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348089	MSH2,APC,TP53,ERCC6
Monarch	HP:0002894	Neoplasm of the pancreas	4	52	2.1	4.96e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000418915	MSH2,APC,TP53,CDKN2A
Monarch	HP:0003002	Breast carcinoma	4	54	2.08	5.01e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,APC,TP53,ATM
Monarch	HP:0000812	Abnormal internal genitalia	6	391	1.4	6.65e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,ATM,ERCC6,AR
Monarch	HP:0006753	Neoplasm of the stomach	4	60	2.04	6.65e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000418915	MSH2,APC,TP53,CDKN2A
Monarch	HP:0002664	Neoplasm	7	763	1.18	0.00010	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,AR,CDKN2A
Monarch	HP:0002888	Ependymoma	3	13	2.58	0.00010	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0012174	Glioblastoma multiforme	3	13	2.58	0.00010	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0002885	Medulloblastoma	3	18	2.44	0.00020	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0006725	Pancreatic adenocarcinoma	3	18	2.44	0.00020	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000418915	MSH2,APC,CDKN2A
Monarch	HP:0009592	Astrocytoma	3	18	2.44	0.00020	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0011024	Abnormality of the gastrointestinal tract	8	1384	0.98	0.00020	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR,CDKN2A
Monarch	HP:0011792	Neoplasm by histology	5	275	1.47	0.00026	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,APC,TP53,ERCC6,CDKN2A
Monarch	HP:0002859	Rhabdomyosarcoma	3	24	2.31	0.00031	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0010787	Genital neoplasm	4	118	1.75	0.00039	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000363822	MSH2,APC,TP53,AR
Monarch	HP:0011442	Abnormal central motor function	8	1689	0.89	0.00052	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR,CDKN2A
Monarch	HP:0030255	Large intestinal polyposis	3	33	2.17	0.00057	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0001909	Leukemia	4	141	1.67	0.00060	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,APC,TP53,ATM
Monarch	HP:0000008	Abnormal morphology of female internal genitalia	5	355	1.36	0.00061	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	MSH2,APC,TP53,ATM,AR
Monarch	HP:0003003	Colon cancer	3	35	2.15	0.00061	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0005978	Type II diabetes mellitus	4	145	1.66	0.00061	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	APC,TP53,ATM,AR
Monarch	HP:0100242	Sarcoma	4	144	1.66	0.00061	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000418915	MSH2,APC,TP53,CDKN2A
Monarch	HP:0100743	Neoplasm of the rectum	3	37	2.12	0.00064	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0000022	Abnormal male internal genitalia morphology	3	38	2.11	0.00067	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000363822	APC,TP53,AR
Monarch	HP:0011793	Neoplasm by anatomical site	6	732	1.13	0.00074	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,ATM,AR,CDKN2A
Monarch	HP:0030065	Primitive neuroectodermal tumor	3	41	2.08	0.00078	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0033019	Male reproductive system neoplasm	3	41	2.08	0.00078	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000363822	APC,TP53,AR
Monarch	HP:0000137	Abnormality of the ovary	4	165	1.6	0.00081	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	MSH2,TP53,ATM,AR
Monarch	HP:0000951	Abnormality of the skin	8	1888	0.84	0.00081	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR,CDKN2A
Monarch	HP:0008069	Neoplasm of the skin	4	175	1.57	0.00096	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000418915	MSH2,APC,TP53,CDKN2A
Monarch	HP:0001402	Hepatocellular carcinoma	3	47	2.02	0.00099	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0010460	Abnormality of the female genitalia	5	422	1.29	0.00099	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	MSH2,APC,TP53,ATM,AR
Monarch	HP:0001000	Abnormality of skin pigmentation	5	439	1.27	0.0011	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,APC,ATM,ERCC6,CDKN2A
Monarch	HP:0001034	Hypermelanotic macule	4	194	1.53	0.0013	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,APC,ATM,ERCC6
Monarch	HP:0007565	Multiple cafe-au-lait spots	3	60	1.91	0.0015	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000278616	MSH2,APC,ATM
Monarch	HP:0001824	Weight loss	4	218	1.48	0.0016	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,APC,TP53,ATM
Monarch	HP:0002039	Anorexia	3	63	1.89	0.0016	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	APC,TP53,ATM
Monarch	HP:0002861	Melanoma	3	61	1.91	0.0016	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000418915	TP53,ERCC6,CDKN2A
Monarch	HP:0033681	Oligodendroglioma	2	5	2.82	0.0016	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0033682	Pleomorphic xanthoastrocytoma	2	5	2.82	0.0016	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0002910	Elevated hepatic transaminase	4	233	1.45	0.0018	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	APC,TP53,ATM,ERCC6
Monarch	HP:0006744	Adrenocortical carcinoma	2	6	2.74	0.0018	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0011747	Abnormality of the anterior pituitary	4	233	1.45	0.0018	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,ERCC6,AR
Monarch	HP:0100031	Neoplasm of the thyroid gland	3	69	1.85	0.0018	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0011029	Internal hemorrhage	4	244	1.43	0.0020	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348089	MSH2,APC,TP53,ERCC6
Monarch	HP:0009732	Plexiform neurofibroma	2	7	2.67	0.0021	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0010785	Gonadal neoplasm	3	76	1.81	0.0023	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000363822	MSH2,TP53,AR
Monarch	HP:0012378	Fatigue	4	258	1.41	0.0024	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,APC,TP53,ATM
Monarch	HP:0000997	Axillary freckling	2	8	2.61	0.0025	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0006771	Duodenal adenocarcinoma	2	8	2.61	0.0025	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0010622	Neoplasm of the skeletal system	3	81	1.78	0.0025	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0011121	Abnormality of skin morphology	7	1648	0.84	0.0025	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,CDKN2A
Monarch	HP:0100605	Neoplasm of the larynx	2	8	2.61	0.0025	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
Monarch	HP:0030012	Abnormal female reproductive system physiology	4	273	1.38	0.0026	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	TP53,ATM,ERCC6,AR
Monarch	HP:0000818	Abnormality of the endocrine system	6	1070	0.96	0.0027	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,ATM,ERCC6,AR
Monarch	HP:0002012	Abnormality of the abdominal organs	6	1068	0.96	0.0027	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,CDKN2A
Monarch	HP:0002715	Abnormality of the immune system	7	1682	0.83	0.0027	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,AR,CDKN2A
Monarch	HP:0006572	Subacute progressive viral hepatitis	2	9	2.56	0.0027	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0100762	Hemobilia	2	9	2.56	0.0027	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0030731	Carcinoma	2	10	2.52	0.0030	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0025032	Abnormality of digestive system physiology	7	1763	0.81	0.0032	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0410019	Epigastric pain	2	11	2.47	0.0034	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0009726	Renal neoplasm	3	98	1.7	0.0035	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0011138	Abnormality of skin adnexa morphology	6	1165	0.93	0.0037	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,ATM,ERCC6,AR,CDKN2A
Monarch	HP:0012190	T-cell lymphoma	2	13	2.4	0.0043	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0000135	Hypogonadism	4	343	1.28	0.0048	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	TP53,ATM,ERCC6,AR
Monarch	HP:0002639	Budd-Chiari syndrome	2	14	2.37	0.0048	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0012050	Anasarca	2	14	2.37	0.0048	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0012842	Skin appendage neoplasm	2	14	2.37	0.0048	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0004370	Abnormality of temperature regulation	4	350	1.27	0.0050	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	APC,TP53,ATM,ERCC6
Monarch	HP:0011355	Localized skin lesion	5	738	1.05	0.0051	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,APC,ATM,ERCC6,CDKN2A
Monarch	HP:0004325	Decreased body weight	6	1274	0.89	0.0052	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,APC,TP53,NTRK2,ATM,ERCC6
Monarch	HP:0000478	Abnormality of the eye	8	2876	0.66	0.0061	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,CDK12,CDKN2A
Monarch	HP:0002480	Hepatic encephalopathy	2	17	2.29	0.0061	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0000029	Testicular atrophy	2	18	2.26	0.0065	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
Monarch	HP:0005227	Adenomatous colonic polyposis	2	18	2.26	0.0065	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0005550	Chronic lymphatic leukemia	2	18	2.26	0.0065	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0012125	Prostate cancer	2	18	2.26	0.0065	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0100523	Liver abscess	2	18	2.26	0.0065	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0002605	Hepatic necrosis	2	19	2.24	0.0068	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0002087	Abnormality of the upper respiratory tract	4	398	1.22	0.0070	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,APC,TP53,ATM
Monarch	HP:0008232	Elevated circulating follicle stimulating hormone level	2	20	2.22	0.0072	9606.ENSP00000348089,9606.ENSP00000363822	ERCC6,AR
Monarch	HP:0012189	Hodgkin lymphoma	2	20	2.22	0.0072	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0000479	Abnormal retinal morphology	5	836	0.99	0.0077	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000418915	APC,TP53,NTRK2,ERCC6,CDKN2A
Monarch	HP:0001413	Micronodular cirrhosis	2	21	2.19	0.0077	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0012719	Functional abnormality of the gastrointestinal tract	5	840	0.99	0.0077	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,NTRK2,ERCC6,AR
Monarch	HP:0010615	Angiofibromas	2	22	2.17	0.0081	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0200063	Colorectal polyposis	2	22	2.17	0.0081	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0001507	Growth abnormality	7	2182	0.72	0.0084	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0011458	Abdominal symptom	6	1448	0.83	0.0085	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,APC,TP53,NTRK2,ATM,ERCC6
Monarch	HP:0012288	Neoplasm of head and neck	2	23	2.15	0.0085	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0001600	Abnormality of the larynx	3	154	1.5	0.0086	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0004364	Abnormal circulating nitrogen compound concentration	4	445	1.17	0.0094	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000363822	APC,TP53,ERCC6,AR
Monarch	HP:0012379	Abnormal enzyme/coenzyme activity	4	447	1.17	0.0095	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	APC,TP53,ATM,ERCC6
Monarch	HP:0001257	Spasticity	5	897	0.96	0.0096	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,TP53,NTRK2,ATM,ERCC6
Monarch	HP:0200114	Metabolic alkalosis	2	25	2.12	0.0096	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0010788	Testicular neoplasm	2	26	2.1	0.0102	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
Monarch	HP:0010876	Abnormal circulating protein concentration	4	466	1.15	0.0105	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	APC,TP53,ATM,AR
Monarch	HP:0002893	Pituitary adenoma	2	27	2.08	0.0106	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0011446	Abnormality of higher mental function	7	2301	0.7	0.0106	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0012126	Stomach cancer	2	27	2.08	0.0106	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0002027	Abdominal pain	3	172	1.46	0.0108	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0001260	Dysarthria	4	480	1.14	0.0114	9606.ENSP00000233146,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,ATM,ERCC6,AR
Monarch	HP:0001288	Gait disturbance	5	951	0.94	0.0117	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,NTRK2,ATM,ERCC6,AR
Monarch	HP:0010461	Abnormality of the male genitalia	5	951	0.94	0.0117	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	APC,TP53,ATM,ERCC6,AR
Monarch	HP:0001337	Tremor	4	492	1.13	0.0122	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	NTRK2,ATM,ERCC6,AR
Monarch	HP:0040276	Adenocarcinoma of the colon	2	30	2.04	0.0122	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0003011	Abnormality of the musculature	7	2384	0.68	0.0124	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0006721	Acute lymphoblastic leukemia	2	31	2.02	0.0126	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
Monarch	HP:0000025	Functional abnormality of male internal genitalia	3	188	1.42	0.0129	9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	ATM,ERCC6,AR
Monarch	HP:0012373	Abnormal eye physiology	7	2405	0.68	0.0129	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000398880	MSH2,APC,TP53,NTRK2,ATM,ERCC6,CDK12
Monarch	HP:0012649	Increased inflammatory response	5	981	0.92	0.0129	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	APC,TP53,ATM,ERCC6,AR
Monarch	HP:0001901	Polycythemia	2	32	2.01	0.0130	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0000505	Visual impairment	5	995	0.92	0.0133	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348089	MSH2,APC,TP53,NTRK2,ERCC6
Monarch	HP:0001315	Reduced tendon reflexes	4	516	1.1	0.0136	9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	NTRK2,ATM,ERCC6,AR
Monarch	HP:0010987	Abnormal cellular immune system morphology	4	517	1.1	0.0136	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,APC,TP53,ATM
Monarch	HP:0000130	Abnormality of the uterus	3	195	1.4	0.0137	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000363822	MSH2,APC,AR
Monarch	HP:0032180	Abnormal circulating metabolite concentration	5	1010	0.91	0.0139	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	APC,TP53,ATM,ERCC6,AR
Monarch	HP:0002216	Premature graying of hair	2	34	1.98	0.0140	9606.ENSP00000278616,9606.ENSP00000348089	ATM,ERCC6
Monarch	HP:0100728	Germ cell neoplasia	2	35	1.97	0.0145	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
Monarch	HP:0003006	Neuroblastoma	2	37	1.95	0.0158	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0005374	Cellular immunodeficiency	2	38	1.94	0.0164	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0011842	Abnormal skeletal morphology	7	2573	0.65	0.0175	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0031466	Impairment in personality functioning	4	566	1.06	0.0175	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120	MSH2,APC,TP53,NTRK2
Monarch	HP:0002040	Esophageal varix	2	41	1.9	0.0183	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0003808	Abnormal muscle tone	6	1773	0.74	0.0183	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0004396	Poor appetite	2	41	1.9	0.0183	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0010741	Pedal edema	2	41	1.9	0.0183	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0002493	Upper motor neuron dysfunction	5	1100	0.87	0.0185	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,TP53,NTRK2,ATM,ERCC6
Monarch	HP:0000777	Abnormality of the thymus	2	42	1.89	0.0187	9606.ENSP00000278616,9606.ENSP00000348089	ATM,ERCC6
Monarch	HP:0000140	Abnormality of the menstrual cycle	3	228	1.33	0.0190	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000363822	TP53,ERCC6,AR
Monarch	HP:0000271	Abnormality of the face	7	2641	0.64	0.0195	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0002315	Headache	3	234	1.32	0.0202	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0001945	Fever	3	238	1.32	0.0210	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616	APC,TP53,ATM
Monarch	HP:0000708	Behavioral abnormality	6	1839	0.73	0.0213	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,APC,TP53,NTRK2,ATM,ERCC6
Monarch	HP:0001098	Abnormal fundus morphology	5	1143	0.86	0.0213	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000418915	APC,TP53,NTRK2,ERCC6,CDKN2A
Monarch	HP:0002671	Basal cell carcinoma	2	46	1.85	0.0213	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0003271	Visceromegaly	4	614	1.03	0.0217	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	APC,TP53,ATM,ERCC6
Monarch	EFO:0009386	Central nervous system disease	3	245	1.3	0.0221	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	TP53,ATM,ERCC6
Monarch	HP:0100649	Neoplasm of the oral cavity	2	49	1.83	0.0234	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0010784	Uterine neoplasm	2	50	1.82	0.0241	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0100543	Cognitive impairment	6	1903	0.71	0.0245	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,APC,TP53,NTRK2,ATM,ERCC6
Monarch	HP:0000656	Ectropion	2	51	1.81	0.0248	9606.ENSP00000257430,9606.ENSP00000348089	APC,ERCC6
Monarch	HP:0003072	Hypercalcemia	2	51	1.81	0.0248	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0002890	Thyroid carcinoma	2	52	1.8	0.0256	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0100615	Ovarian neoplasm	2	52	1.8	0.0256	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
Monarch	HP:0001871	Abnormality of blood and blood-forming tissues	5	1214	0.83	0.0259	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	MSH2,APC,TP53,ATM,ERCC6
Monarch	HP:0005293	Venous insufficiency	2	54	1.78	0.0268	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0012795	Abnormal optic disc morphology	4	670	0.99	0.0278	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348089	APC,TP53,NTRK2,ERCC6
Monarch	HP:0009804	Tooth agenesis	3	273	1.26	0.0280	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000348089	APC,NTRK2,ERCC6
Monarch	HP:0000118	Phenotypic abnormality	9	5129	0.46	0.0281	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR,CDK12,CDKN2A
Monarch	HP:0001274	Agenesis of corpus callosum	3	275	1.25	0.0281	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000348089	MSH2,APC,ERCC6
Monarch	HP:0001298	Encephalopathy	3	276	1.25	0.0281	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120	APC,TP53,NTRK2
Monarch	HP:0012732	Anorectal anomaly	3	274	1.25	0.0281	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305	MSH2,APC,TP53
Monarch	HP:0025615	Abscess	2	56	1.77	0.0281	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	EFO:0004632	Nevus count	2	57	1.76	0.0284	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
Monarch	HP:0000002	Abnormality of body height	5	1253	0.82	0.0284	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0001085	Papilledema	2	58	1.75	0.0290	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0001894	Thrombocytosis	2	58	1.75	0.0290	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0012337	Abnormal homeostasis	5	1275	0.81	0.0299	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	APC,TP53,ATM,ERCC6,AR
Monarch	HP:0002516	Increased intracranial pressure	2	61	1.73	0.0313	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
Monarch	HP:0002898	Embryonal neoplasm	2	61	1.73	0.0313	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0007364	Aplasia/Hypoplasia of the cerebrum	5	1300	0.8	0.0322	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348089	MSH2,APC,TP53,NTRK2,ERCC6
Monarch	HP:0006483	Abnormal number of teeth	3	296	1.22	0.0326	9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000348089	APC,NTRK2,ERCC6
Monarch	HP:0001409	Portal hypertension	2	63	1.72	0.0327	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0002902	Hyponatremia	2	64	1.71	0.0336	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0012372	Abnormal eye morphology	6	2077	0.68	0.0341	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	APC,TP53,NTRK2,ATM,ERCC6,CDKN2A
Monarch	HP:0002018	Nausea	2	65	1.7	0.0343	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0032263	Increased blood pressure	3	303	1.21	0.0343	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348089	APC,TP53,ERCC6
Monarch	EFO:0004842	Eosinophil count	4	734	0.95	0.0349	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386593,9606.ENSP00000418915	TP53,ATM,PBRM1,CDKN2A
Monarch	HP:0003073	Hypoalbuminemia	2	66	1.7	0.0349	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0002014	Diarrhea	3	309	1.2	0.0353	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348089	APC,TP53,ERCC6
Monarch	HP:0002900	Hypokalemia	2	67	1.69	0.0353	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0012116	Abnormal circulating albumin concentration	2	67	1.69	0.0353	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0010978	Abnormality of immune system physiology	5	1347	0.78	0.0355	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	APC,TP53,ATM,ERCC6,AR
Monarch	HP:0002167	Neurological speech impairment	5	1354	0.78	0.0362	9606.ENSP00000233146,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,NTRK2,ATM,ERCC6,AR
Monarch	HP:0002653	Bone pain	2	73	1.65	0.0405	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0002797	Osteolysis	2	73	1.65	0.0405	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
Monarch	HP:0000119	Abnormality of the genitourinary system	6	2189	0.65	0.0420	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,ATM,ERCC6,AR
Monarch	HP:0001273	Abnormal corpus callosum morphology	4	784	0.92	0.0421	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000277120,9606.ENSP00000348089	MSH2,APC,NTRK2,ERCC6
Monarch	HP:0009121	Abnormal axial skeleton morphology	6	2206	0.65	0.0433	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	APC,TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0000035	Abnormal testis morphology	4	793	0.92	0.0435	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	TP53,ATM,ERCC6,AR
Monarch	HP:0100835	Benign neoplasm of the central nervous system	2	78	1.62	0.0448	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
Monarch	HP:0033127	Abnormality of the musculoskeletal system	7	3173	0.56	0.0449	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ATM,ERCC6,AR
Monarch	HP:0012443	Abnormality of brain morphology	6	2254	0.64	0.0475	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,APC,TP53,NTRK2,ERCC6,AR
Monarch	HP:0001265	Hyporeflexia	3	353	1.14	0.0477	9606.ENSP00000277120,9606.ENSP00000348089,9606.ENSP00000363822	NTRK2,ERCC6,AR
Monarch	HP:0011354	Generalized abnormality of skin	4	821	0.9	0.0481	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089	APC,TP53,ATM,ERCC6
DISEASES	DOID:229	Female reproductive system disease	7	192	1.78	3.35e-08	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,AR,CDKN2A
DISEASES	DOID:0050686	Organ system cancer	9	757	1.29	8.79e-08	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,AR,PBRM1,CDKN2A
DISEASES	DOID:4159	Skin cancer	5	63	2.11	3.76e-07	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,CDKN2A
DISEASES	DOID:345	Uterine disease	5	72	2.06	4.06e-07	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,CDKN2A
DISEASES	DOID:0050687	Cell type cancer	7	451	1.41	1.28e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,AR,PBRM1,CDKN2A
DISEASES	DOID:289	Endometriosis	4	34	2.29	2.64e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000418915	MSH2,TP53,PGR,CDKN2A
DISEASES	DOID:299	Adenocarcinoma	5	119	1.84	2.90e-06	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	TP53,PGR,AR,PBRM1,CDKN2A
DISEASES	DOID:16	Integumentary system disease	7	575	1.3	4.99e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,AR,CDKN2A
DISEASES	DOID:305	Carcinoma	6	307	1.51	4.99e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,TP53,PGR,AR,PBRM1,CDKN2A
DISEASES	DOID:363	Uterine cancer	4	46	2.15	5.86e-06	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000418915	MSH2,TP53,PGR,CDKN2A
DISEASES	DOID:3119	Gastrointestinal system cancer	5	161	1.71	9.23e-06	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,PBRM1,CDKN2A
DISEASES	DOID:193	Reproductive organ cancer	5	167	1.69	1.03e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,TP53,PGR,AR,CDKN2A
DISEASES	DOID:10155	Intestinal cancer	4	59	2.05	1.24e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000418915	MSH2,APC,TP53,CDKN2A
DISEASES	DOID:1612	Breast cancer	4	62	2.02	1.42e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000418915	TP53,ATM,PGR,CDKN2A
DISEASES	DOID:28	Endocrine system disease	6	398	1.39	1.44e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,ERCC6,AR,CDKN2A
DISEASES	DOID:0060085	Organ system benign neoplasm	5	237	1.54	4.13e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000418915	MSH2,APC,TP53,PGR,CDKN2A
DISEASES	DOID:3996	Urinary system cancer	4	89	1.87	4.46e-05	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386593,9606.ENSP00000418915	TP53,ATM,PBRM1,CDKN2A
DISEASES	DOID:37	Skin disease	6	518	1.28	5.08e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,CDKN2A
DISEASES	DOID:1100	Ovarian disease	4	109	1.78	8.03e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000363822	MSH2,TP53,ERCC6,AR
DISEASES	DOID:1380	Endometrial cancer	3	25	2.29	8.87e-05	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000325120	MSH2,TP53,PGR
DISEASES	DOID:3459	Breast carcinoma	3	29	2.23	0.00013	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000418915	TP53,PGR,CDKN2A
DISEASES	DOID:11054	Urinary bladder cancer	3	38	2.11	0.00027	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
DISEASES	DOID:11166	Obsolete papillomavirus infectious disease	2	2	3.22	0.00029	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:5672	Large intestine cancer	3	44	2.05	0.00038	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000418915	APC,TP53,CDKN2A
DISEASES	DOID:1909	Melanoma	3	46	2.03	0.00042	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000418915	TP53,ATM,CDKN2A
DISEASES	DOID:12704	Ataxia telangiectasia	2	5	2.82	0.00087	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
DISEASES	DOID:3008	Invasive ductal carcinoma	2	5	2.82	0.00087	9606.ENSP00000269305,9606.ENSP00000325120	TP53,PGR
DISEASES	DOID:657	Adenoma	3	66	1.87	0.00099	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000325120	APC,TP53,PGR
DISEASES	DOID:3012	Li-Fraumeni syndrome	2	6	2.74	0.0010	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:3498	Pancreatic ductal adenocarcinoma	2	6	2.74	0.0010	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:13223	Uterine fibroid	2	7	2.67	0.0013	9606.ENSP00000269305,9606.ENSP00000325120	TP53,PGR
DISEASES	DOID:8557	Oropharynx cancer	2	7	2.67	0.0013	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:2871	Endometrial carcinoma	2	9	2.56	0.0018	9606.ENSP00000269305,9606.ENSP00000325120	TP53,PGR
DISEASES	DOID:2893	Cervix carcinoma	2	9	2.56	0.0018	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:9561	Nasopharyngeal disease	2	9	2.56	0.0018	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:0050424	Familial adenomatous polyposis	2	10	2.52	0.0020	9606.ENSP00000233146,9606.ENSP00000257430	MSH2,APC
DISEASES	DOID:0060108	Brain glioma	2	10	2.52	0.0020	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:2059	Vulvar disease	2	11	2.47	0.0023	9606.ENSP00000325120,9606.ENSP00000418915	PGR,CDKN2A
DISEASES	DOID:5520	Head and neck squamous cell carcinoma	2	11	2.47	0.0023	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:7	Disease of anatomical entity	10	4798	0.53	0.0024	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,AR,PBRM1,CDKN2A
DISEASES	DOID:0050621	Respiratory system benign neoplasm	2	12	2.44	0.0025	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:8923	Skin melanoma	2	12	2.44	0.0025	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:3910	Lung adenocarcinoma	2	13	2.4	0.0027	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:8719	In situ carcinoma	2	13	2.4	0.0027	9606.ENSP00000269305,9606.ENSP00000325120	TP53,PGR
DISEASES	DOID:3068	Glioblastoma multiforme	2	14	2.37	0.0030	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:786	Laryngeal disease	2	14	2.37	0.0030	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:768	Retinoblastoma	2	16	2.31	0.0034	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:1795	Tumor of exocrine pancreas	2	17	2.29	0.0037	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:8618	Oral cavity cancer	2	18	2.26	0.0040	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:3908	Lung non-small cell carcinoma	2	26	2.1	0.0075	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:2513	Basal cell carcinoma	2	27	2.08	0.0080	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
DISEASES	DOID:9256	Colorectal cancer	2	32	2.01	0.0104	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
DISEASES	DOID:0060099	Musculoskeletal system benign neoplasm	2	35	1.97	0.0119	9606.ENSP00000257430,9606.ENSP00000325120	APC,PGR
DISEASES	DOID:4947	Cholangiocarcinoma	2	40	1.91	0.0149	9606.ENSP00000269305,9606.ENSP00000386593	TP53,PBRM1
DISEASES	DOID:9553	Adrenal gland disease	2	46	1.85	0.0181	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
DISEASES	DOID:5353	Colonic disease	2	50	1.82	0.0208	9606.ENSP00000257430,9606.ENSP00000269305	APC,TP53
DISEASES	DOID:263	Kidney cancer	2	51	1.81	0.0214	9606.ENSP00000269305,9606.ENSP00000386593	TP53,PBRM1
DISEASES	DOID:331	Central nervous system disease	5	1199	0.84	0.0214	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000363822,9606.ENSP00000418915	TP53,NTRK2,ATM,AR,CDKN2A
DISEASES	DOID:225	Syndrome	5	1214	0.83	0.0222	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	MSH2,TP53,ATM,ERCC6,CDKN2A
DISEASES	DOID:2394	Ovarian cancer	2	55	1.78	0.0235	9606.ENSP00000233146,9606.ENSP00000269305	MSH2,TP53
DISEASES	DOID:5679	Retinal disease	3	309	1.2	0.0337	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000418915	TP53,ERCC6,CDKN2A
DISEASES	DOID:3856	Male reproductive organ cancer	2	75	1.64	0.0401	9606.ENSP00000363822,9606.ENSP00000418915	AR,CDKN2A
DISEASES	DOID:936	Brain disease	4	806	0.91	0.0437	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000418915	TP53,NTRK2,ATM,CDKN2A
DISEASES	DOID:201	Connective tissue cancer	2	82	1.6	0.0460	9606.ENSP00000269305,9606.ENSP00000277120	TP53,NTRK2
DISEASES	DOID:863	Nervous system disease	6	2275	0.64	0.0469	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	TP53,NTRK2,ATM,ERCC6,AR,CDKN2A
DISEASES	DOID:0050177	Monogenic disease	7	3266	0.55	0.0494	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,AR,CDKN2A
TISSUES	BTO:0001271	Leukemia cell	7	1067	1.03	0.0021	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000362649,9606.ENSP00000398880	MSH2,APC,TP53,ATM,PGR,HDAC1,CDK12
TISSUES	BTO:0000458	WI-38 cell	2	2	3.22	0.0025	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
TISSUES	BTO:0005257	Oropharynx	2	2	3.22	0.0025	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
TISSUES	BTO:0001321	LNCaP cell	2	6	2.74	0.0035	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
TISSUES	BTO:0001332	DU-145 cell	2	5	2.82	0.0035	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
TISSUES	BTO:0001938	U2-OS cell	2	5	2.82	0.0035	9606.ENSP00000269305,9606.ENSP00000278616	TP53,ATM
TISSUES	BTO:0000453	Fibroblast cell line	3	75	1.82	0.0036	9606.ENSP00000269305,9606.ENSP00000363822,9606.ENSP00000418915	TP53,AR,CDKN2A
TISSUES	BTO:0000669	Embryonic cell line	3	73	1.83	0.0036	9606.ENSP00000269305,9606.ENSP00000363822,9606.ENSP00000418915	TP53,AR,CDKN2A
TISSUES	BTO:0001130	Prostate gland cancer cell	2	7	2.67	0.0036	9606.ENSP00000269305,9606.ENSP00000363822	TP53,AR
TISSUES	BTO:0000815	MDA-MB-231 cell	2	9	2.56	0.0041	9606.ENSP00000269305,9606.ENSP00000325120	TP53,PGR
TISSUES	BTO:0000093	MCF-7 cell	2	11	2.47	0.0053	9606.ENSP00000269305,9606.ENSP00000325120	TP53,PGR
TISSUES	BTO:0000167	Adenocarcinoma cell line	3	107	1.66	0.0067	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000363822	TP53,PGR,AR
TISSUES	BTO:0001033	Prostate cancer cell line	3	108	1.66	0.0067	9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000363822	TP53,HDAC1,AR
TISSUES	BTO:0000744	Lymphocytic leukemia cell	4	419	1.2	0.0105	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000362649,9606.ENSP00000398880	APC,TP53,HDAC1,CDK12
TISSUES	BTO:0001090	Mouth	4	532	1.09	0.0217	9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000363822,9606.ENSP00000418915	TP53,NTRK2,AR,CDKN2A
TISSUES	BTO:0001541	Pronephros	3	219	1.35	0.0258	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616	MSH2,TP53,ATM
TISSUES	BTO:0000452	Fibroblast	3	224	1.34	0.0266	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000363822	TP53,ATM,AR
TISSUES	BTO:0000089	Blood	6	1824	0.73	0.0290	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000363822	MSH2,APC,TP53,ATM,HDAC1,AR
TISSUES	BTO:0000570	Hematopoietic system	7	2755	0.62	0.0340	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000418915	MSH2,APC,TP53,ATM,HDAC1,AR,CDKN2A
TISSUES	BTO:0001488	Endocrine gland	10	6403	0.41	0.0340	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880	MSH2,APC,TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12
TISSUES	BTO:0000416	Epithelium	4	697	0.97	0.0459	9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000363822,9606.ENSP00000418915	TP53,PGR,AR,CDKN2A
COMPARTMENTS	GOCC:0005654	Nucleoplasm	10	1146	1.16	6.32e-08	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
COMPARTMENTS	GOCC:1902494	Catalytic complex	9	1710	0.94	3.79e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,ATM,ERCC6,HDAC1,PBRM1,CDK12,CDKN2A
COMPARTMENTS	GOCC:0000785	Chromatin	6	476	1.32	9.72e-05	9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	TP53,ERCC6,HDAC1,AR,PBRM1,CDKN2A
COMPARTMENTS	GOCC:0005694	Chromosome	7	951	1.08	0.00012	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	APC,TP53,ERCC6,HDAC1,AR,PBRM1,CDKN2A
COMPARTMENTS	GOCC:1904949	ATPase complex	4	120	1.74	0.00018	9606.ENSP00000233146,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593	MSH2,ERCC6,HDAC1,PBRM1
COMPARTMENTS	GOCC:0005634	Nucleus	11	4787	0.58	0.00038	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
COMPARTMENTS	GOCC:0009341	Beta-galactosidase complex	2	3	3.04	0.00071	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
COMPARTMENTS	GOCC:0032991	Protein-containing complex	11	5325	0.53	0.00098	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
COMPARTMENTS	GOCC:0070603	SWI/SNF superfamily-type complex	3	95	1.71	0.0045	9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000386593	ERCC6,HDAC1,PBRM1
COMPARTMENTS	GOCC:0043227	Membrane-bounded organelle	12	9083	0.34	0.0152	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
COMPARTMENTS	GOCC:0043229	Intracellular organelle	12	9609	0.31	0.0255	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
COMPARTMENTS	GOCC:0043232	Intracellular non-membrane-bounded organelle	8	3309	0.6	0.0255	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000418915	APC,TP53,ATM,ERCC6,HDAC1,AR,PBRM1,CDKN2A
COMPARTMENTS	GOCC:0005730	Nucleolus	4	606	1.03	0.0447	9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000348089,9606.ENSP00000418915	TP53,ATM,ERCC6,CDKN2A
UniProt Keywords	KW-0043	Tumor suppressor	6	177	1.75	3.50e-07	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000386593,9606.ENSP00000418915	MSH2,APC,TP53,ATM,PBRM1,CDKN2A
UniProt Keywords	KW-0832	Ubl conjugation	10	2399	0.84	1.28e-05	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880	MSH2,APC,TP53,NTRK2,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12
UniProt Keywords	KW-1017	Isopeptide bond	8	1717	0.88	0.00027	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880	MSH2,TP53,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12
UniProt Keywords	KW-0435	Li-Fraumeni syndrome	2	3	3.04	0.00057	9606.ENSP00000269305,9606.ENSP00000418915	TP53,CDKN2A
UniProt Keywords	KW-0597	Phosphoprotein	12	8122	0.38	0.0033	9606.ENSP00000233146,9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000277120,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,APC,TP53,NTRK2,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
UniProt Keywords	KW-0877	Alternative promoter usage	3	95	1.71	0.0033	9606.ENSP00000257430,9606.ENSP00000269305,9606.ENSP00000325120	APC,TP53,PGR
UniProt Keywords	KW-0238	DNA-binding	7	1971	0.77	0.0049	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000363822,9606.ENSP00000386593	MSH2,TP53,ATM,PGR,ERCC6,AR,PBRM1
UniProt Keywords	KW-0539	Nucleus	10	5278	0.49	0.0054	9606.ENSP00000233146,9606.ENSP00000269305,9606.ENSP00000278616,9606.ENSP00000325120,9606.ENSP00000348089,9606.ENSP00000362649,9606.ENSP00000363822,9606.ENSP00000386593,9606.ENSP00000398880,9606.ENSP00000418915	MSH2,TP53,ATM,PGR,ERCC6,HDAC1,AR,PBRM1,CDK12,CDKN2A
UniProt Keywords	KW-0754	Steroid-binding	2	18	2.26	0.0054	9606.ENSP00000325120,9606.ENSP00000363822	PGR,AR
